8-K: Xtant Medical Holdings Announces Results of 2024 Annual Stockholders Meeting
Annual Meeting Results
Xtant Medical Holdings held its 2024 annual meeting of stockholders on July 23, 2024, where all proposed directors were elected, the appointment of Grant Thornton LLP as auditor was ratified, and executive compensation was approved on an advisory basis.
Summary
- Xtant Medical Holdings held its 2024 annual meeting of stockholders on July 23, 2024.
- A total of 105,850,527 shares were represented at the meeting, which is 81.25% of the 130,268,590 outstanding shares as of the record date of May 28, 2024.
- The stockholders voted on three proposals.
- All six director nominees were elected to the board.
- The appointment of Grant Thornton LLP as the company's independent auditor for the year ending December 31, 2024, was ratified.
- The compensation of the company's executive officers was approved on an advisory basis.
Sentiment
Score: 7
Explanation: The document reflects a routine annual meeting with expected outcomes, indicating a neutral to slightly positive sentiment due to the successful completion of standard procedures.
Positives
- All proposed directors were successfully elected, indicating shareholder support for the board.
- The ratification of Grant Thornton LLP as the auditor provides continuity and stability in financial oversight.
- The advisory approval of executive compensation suggests shareholder alignment with the company's pay practices.
Industry Context
This announcement is a routine update following the company's annual meeting, which is a standard practice for publicly traded companies. The results reflect the shareholders' decisions on key governance matters.
Comparison to Industry Standards
- The election of directors and ratification of auditors are standard procedures for publicly traded companies, and Xtant's process appears to be in line with industry norms.
- The advisory vote on executive compensation is also a common practice, allowing shareholders to express their views on pay practices.
Stakeholder Impact
- Shareholders have exercised their voting rights on key governance matters.
- The election of directors ensures the continuation of board oversight.
- The ratification of the auditor provides assurance of financial integrity.
Key Dates
| Date | Description |
|---|---|
| 2024-05-28 | Record date for the annual meeting. |
| 2024-06-10 | Date the definitive proxy statement was filed with the SEC. |
| 2024-07-23 | Date of the 2024 annual meeting of stockholders. |
| 2024-07-24 | Date of the report. |
Keywords
Annual Meeting, Stockholders, Board of Directors, Director Election, Auditor Ratification, Executive Compensation, Voting Results, Proxy Statement, Grant Thornton, XTNT
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.